Contacts between organelles create microdomains that play major roles in regulating key intracellular activities and signaling pathways, but whether they also regulate systemic functions remains unknown. Here, we report the ultrastructural organization and dynamics of the inter-organellar contact established by sheets of curved rough endoplasmic reticulum closely wrapped around the mitochondria (wrappER). To elucidate the in vivo function of this contact, mouse liver fractions enriched in wrappER-associated mitochondria are analyzed by transcriptomics, proteomics, and lipidomics. The biochemical signature of the wrappER points to a role in the biogenesis of very-low-density lipoproteins (VLDL). Altering wrappER-mitochondria contacts curtails VLDL secretion and increases hepatic fatty acids, lipid droplets, and neutral lipid content. Conversely, acute liver-specific ablation of Mttp, the most upstream regulator of VLDL biogenesis, recapitulates this hepatic dyslipidemia phenotype and promotes remodeling of the wrappER-mitochondria contact. The discovery that liver wrappER-mitochondria contacts participate in VLDL biology suggests an involvement of inter-organelle contacts in systemic lipid homeostasis.
Pubmed ID: 33730569 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Randomized controlled trial being conducted at two clinical centers in the United States to learn more about the effects of weight loss on urinary incontinence. About 330 overweight women aged 30 or older will participate and will be followed for 18 months. Efficacy of weight reduction as a treatment for urinary incontinence will be examined at 6 months following the intensive weight control program, and the sustained impact of the intervention will be examined at 18 months. To increase the maintenance of weight reduction and facilitate evaluation of the enduring impact of weight loss on urinary incontinence, they propose to study a motivation-based weight maintenance program. At the end of the intensive weight control program, women randomized to the weight loss program will be randomized to either a 12-month skill-based maintenance intervention or to a motivation-based maintenance intervention. The maintenance interventions maximize the potential for sustained weight loss and will allow them to determine if long-term weight reduction will produce continued improvement in urinary incontinence.
View all literature mentionslaboratory mouse with name C57BL/6N from MGI.
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets Full length recombinant GFP
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets IgG
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis monoclonal targets Apolipoprotein E
View all literature mentionsThis polyclonal targets COX16
View all literature mentionsThis monoclonal targets Phospho-S6 Ribosomal Protein (Ser240/244) (D68F8) XP Rabbit mAb
View all literature mentionsThis monoclonal targets S6 Ribosomal Protein (54D2) Mouse mAb
View all literature mentionsThis polyclonal targets RRBP1 antibody
View all literature mentionsThis monoclonal targets PMP70 antibody produced in mouse
View all literature mentionsThis monoclonal targets OPA1
View all literature mentionsThis polyclonal targets MTTP
View all literature mentionsThis unknown targets Mn SOD
View all literature mentionsThis monoclonal targets GM130
View all literature mentionsThis monoclonal targets GFP
View all literature mentionsThis monoclonal targets cathepsin C (D-6)
View all literature mentionsThis recombinant monoclonal targets Catalase
View all literature mentionsThis monoclonal targets Calreticulin
View all literature mentionsThis unknown targets A 19 residue synthetic peptide based on dog calnexin and the peptide coupled to KLH
View all literature mentionsThis monoclonal targets BiP
View all literature mentionsThis polyclonal targets Na,K-ATPase alpha 1
View all literature mentionsThis polyclonal targets APOE
View all literature mentionsThis polyclonal targets Apolipoprotein E
View all literature mentionsThis polyclonal targets Apolipoprotein B
View all literature mentionsThis polyclonal targets Apolipoprotein B
View all literature mentionsThis polyclonal targets Albumin
View all literature mentionsThis monoclonal targets ADFP antibody [EPR3713]
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsMus musculus with name C57BL/6NCrl from IMSR.
View all literature mentions